Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Safe Sex | 1 | 2019 | 144 | 0.650 |
Why?
|
| Opioid-Related Disorders | 3 | 2021 | 2164 | 0.580 |
Why?
|
| Risk-Taking | 2 | 2019 | 1038 | 0.470 |
Why?
|
| HIV Infections | 7 | 2022 | 17351 | 0.450 |
Why?
|
| Social Stigma | 1 | 2020 | 769 | 0.430 |
Why?
|
| Inpatients | 3 | 2022 | 2548 | 0.410 |
Why?
|
| Sexual Behavior | 1 | 2019 | 2180 | 0.340 |
Why?
|
| Mass Screening | 4 | 2021 | 5428 | 0.330 |
Why?
|
| Substance-Related Disorders | 2 | 2022 | 4420 | 0.270 |
Why?
|
| Homosexuality, Male | 5 | 2022 | 1334 | 0.270 |
Why?
|
| Osteoarthritis, Knee | 4 | 2015 | 1234 | 0.220 |
Why?
|
| Mood Disorders | 3 | 2016 | 1127 | 0.220 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2021 | 4575 | 0.220 |
Why?
|
| Mental Disorders | 2 | 2020 | 6845 | 0.210 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2020 | 303 | 0.160 |
Why?
|
| Trust | 1 | 2021 | 530 | 0.140 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2022 | 1988 | 0.140 |
Why?
|
| Anti-HIV Agents | 2 | 2022 | 4527 | 0.130 |
Why?
|
| Unsafe Sex | 1 | 2017 | 238 | 0.120 |
Why?
|
| Consensus | 2 | 2014 | 3123 | 0.110 |
Why?
|
| Disclosure | 1 | 2019 | 748 | 0.110 |
Why?
|
| Patient-Centered Care | 2 | 2014 | 1421 | 0.110 |
Why?
|
| Evidence-Based Medicine | 3 | 2015 | 3688 | 0.110 |
Why?
|
| Hyaluronic Acid | 2 | 2015 | 483 | 0.110 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 1089 | 0.100 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2014 | 432 | 0.100 |
Why?
|
| Antimanic Agents | 1 | 2015 | 520 | 0.100 |
Why?
|
| Bipolar Disorder | 4 | 2016 | 5092 | 0.100 |
Why?
|
| Sensitivity and Specificity | 4 | 2021 | 14666 | 0.100 |
Why?
|
| Adult | 13 | 2022 | 221177 | 0.090 |
Why?
|
| Placebo Effect | 1 | 2015 | 518 | 0.090 |
Why?
|
| Male | 15 | 2022 | 360804 | 0.090 |
Why?
|
| Vaccination | 1 | 2021 | 3384 | 0.080 |
Why?
|
| Borderline Personality Disorder | 1 | 2016 | 768 | 0.080 |
Why?
|
| Patient Readmission | 1 | 2022 | 3270 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2015 | 2273 | 0.070 |
Why?
|
| Humans | 23 | 2022 | 761504 | 0.070 |
Why?
|
| Biological Products | 1 | 2015 | 914 | 0.070 |
Why?
|
| Antidepressive Agents | 2 | 2015 | 2897 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2015 | 2161 | 0.070 |
Why?
|
| Antirheumatic Agents | 1 | 2015 | 1372 | 0.060 |
Why?
|
| Female | 11 | 2022 | 392644 | 0.060 |
Why?
|
| Poverty | 2 | 2013 | 2698 | 0.060 |
Why?
|
| Pandemics | 2 | 2021 | 8654 | 0.060 |
Why?
|
| Depression | 2 | 2021 | 8124 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 4016 | 0.050 |
Why?
|
| Depressive Disorder | 1 | 2014 | 3728 | 0.050 |
Why?
|
| Young Adult | 4 | 2022 | 59243 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2015 | 3763 | 0.040 |
Why?
|
| Medication Adherence | 2 | 2022 | 2176 | 0.040 |
Why?
|
| Primary Health Care | 2 | 2013 | 4686 | 0.040 |
Why?
|
| Quality of Life | 1 | 2021 | 13367 | 0.040 |
Why?
|
| Middle Aged | 9 | 2022 | 220895 | 0.040 |
Why?
|
| Personality Inventory | 1 | 2022 | 1019 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 10209 | 0.040 |
Why?
|
| Personality | 1 | 2022 | 554 | 0.040 |
Why?
|
| Personality Disorders | 1 | 2022 | 722 | 0.040 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 26125 | 0.030 |
Why?
|
| ROC Curve | 1 | 2021 | 3579 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2015 | 597 | 0.030 |
Why?
|
| Chile | 1 | 2013 | 256 | 0.030 |
Why?
|
| Injections, Intra-Articular | 1 | 2013 | 280 | 0.030 |
Why?
|
| General Practitioners | 1 | 2013 | 101 | 0.030 |
Why?
|
| Psychomotor Agitation | 1 | 2014 | 305 | 0.020 |
Why?
|
| Review Literature as Topic | 1 | 2014 | 348 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2022 | 5247 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2013 | 809 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2014 | 1380 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2022 | 8631 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2021 | 7045 | 0.020 |
Why?
|
| International Cooperation | 1 | 2014 | 1422 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 1880 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 6310 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 3808 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2015 | 3905 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2015 | 64680 | 0.010 |
Why?
|
| Recurrence | 1 | 2015 | 8465 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2016 | 5079 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 12974 | 0.010 |
Why?
|
| Risk Factors | 2 | 2021 | 74206 | 0.010 |
Why?
|
| United States | 2 | 2021 | 72334 | 0.010 |
Why?
|
| Pain | 1 | 2015 | 5073 | 0.010 |
Why?
|
| Aged | 3 | 2022 | 169289 | 0.010 |
Why?
|
| Comorbidity | 1 | 2014 | 10508 | 0.010 |
Why?
|
| Age Factors | 1 | 2014 | 18395 | 0.010 |
Why?
|
| Depressive Disorder, Major | 1 | 2014 | 4761 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 20098 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 39106 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 39967 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 88319 | 0.000 |
Why?
|
Concepts
(90)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_